Benzinga's Top Upgrades

Analysts at Deutsche Bank upgraded LifePoint Hospitals (NASDAQ: LPNT ) from “hold” to “buy.” The target price for LifePoint Hospitals has been raised from $56 to $61. LifePoint Hospitals' shares closed at $50.93 yesterday. Analysts at Oppenheimer upgraded Zogenix (NASDAQ: ZGNX ) from “perform to “outperform.” The target price